Breast Abnormalities Clinical Trial
Official title:
Imaging Protocol Design for Anti-Angiogenesis Tracking With MRI
Preliminary imaging study to test for future use of this MRI-imaging for evaluating anti-angiogenesis treatment.
The purpose of this study is to develop and evaluate new MR imaging techniques and protocols
for non-invasive monitoring of anti-angiogenesis treatment of breast cancer. This
feasibility study is a preliminary imaging study to test this imaging protocol on subjects
already undergoing MR for clinical purposes.
The specific objective of this research study is to develop and validate both MRI and
functional MRI data acquisition methods, task paradigms, and post-processing techniques to
ensure reliability of results.
The information derived from this research is intended to be applied to a future study of
subjects undergoing experimental anti-angiogenesis drug therapy.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01687790 -
The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease
|
N/A | |
| Recruiting |
NCT01106911 -
Assessment of Digital Breast Tomosynthesis (DBT) in the Screening Environment
|
N/A | |
| Active, not recruiting |
NCT02406274 -
Use of Contrast Enhanced Spectral Mammography (CESM) for Women With Palpable Breast Abnormalities
|
N/A | |
| Completed |
NCT00722059 -
Detection and/or Evaluation of Dense Breast Abnormalities Using Tomosynthesis and Digital Mammography
|
Phase 0 | |
| Withdrawn |
NCT00722683 -
Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts
|
N/A |